Viewpoint Molecular Targeting, LLC develops pharmaceutical drugs for diagnostic imaging and therapy for cancer, with a focus on metastatic melanoma. Our novel image-guided therapies enable a personalized approach to selecting patients that can benefit the most from our targeted therapies. Viewpoint's unique “theranostic” agents possess properties that enable doctors to both image and treat cancer, personalizing the selection of patients and optimizing their care.

Contact Information
Michael Schultz, Ph.D., CSO
Viewpoint Molecular Targeting
2500 Crosspark Rd, E116
Coralville, IA 52241
United States
Phone Number: 
(865) 665-2150